Four faculty members will present eight short vingettes of challenging patients and discuss diagnosis and management of the specific diagnoses. Collectively, these four pediatric neurology faculty members have over 100 years of experience caring for children with these eight diagnoses. Topics will cover neuroimmunology (childhood MS and CNS vasculitis, CIDP, and MG) and neuromuscular disorders OTHER than DMD and SMA (diagnosis and management and updates on childhood LGMD, Myotonic dystrophy, and two mysteries).

Completion Message:

Participants will understand how to approach the diagnosis of children with challenging childhood neuromuscular and neuroimmunology disorders involving both CNS and PNS.

CME Credits:

2

Core Competencies:

Patient Care, Medical Knowledge

Program Speakers - Tentative

Start/End Time

Title

Faculty

7:00 AM - 7:30 AM

What Are Those Autoantibodies Doing? (Part 1)

Soe Soe Mar MD, FAAN

7:30 AM - 8:00 AM

Besides DMD and SMA, What Else Can Happen? (Part 1)

Katherine D. Mathews MD, FAAN

8:00 AM - 8:30 AM

Besides DMD and SMA, What Else Can Happen? (Part 2)

Russell Butterfield MD, PhD, BS

8:30 AM - 9:00 AM

What Are Those Autoantibodies Doing? (Part 2)

Anne M. Connolly MD, FAAN

Disclosures

Speaker

Disclosure

Russell Butterfield, MD, PhD, BS

Dr. Butterfield has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sarepta Therapeutics and Biogen. Dr. Butterfield has received research support from PTC Therapeutics, Sarepta Therapeutics, Pfizer, and, Biogen.

Anne M. Connolly, MD, FAAN

Dr. Connolly has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sarepta, Avexis, Catabasis, Genzyme, Roche. Dr. Connolly has received research support from Sarepta, Biogen, PTC, Pfizer, Fibrogen, BMS, Cytokinetics, NS Pharma, Roche, AveXis, Italfarmaco.

Soe Soe Mar, MD, FAAN

Dr. Mar has nothing to disclose.

Katherine D. Mathews, MD, FAAN

Dr. Mathews has received research support from Sarepta, Pfizer, Santhera, Roche, Fibrogen, Intalfarmaco, AMO, Reata, Takeda, and Acceleron.